Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Yoga in Treating Sleep Disturbance in Cancer Survivors

ClinicalTrials.gov ID: NCT00397930

Public ClinicalTrials.gov record NCT00397930. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 11:00 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Yoga for Persistent Sleep Disturbance in Cancer Survivors

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Yoga may help improve sleep, fatigue, and quality of life in cancer survivors. PURPOSE: This phase II trial is studying how well yoga works in treating sleep disturbance in cancer survivors.

Study identification

NCT ID
NCT00397930
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gary Morrow
Other
Enrollment
410 participants

Conditions and interventions

Eligibility (public fields only)

Age range
21 Years to 120 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2006 (Type not available)
Primary completion
Apr 2013 (Actual)
Completion
Jun 2013 (Actual)
Last update posted
Feb 20, 2017

2006 – 2013

United States locations

U.S. sites
11
U.S. states
10
U.S. cities
11
Facility City State ZIP Site status
CCOP - Central Illinois Decatur Illinois 62526 —
CCOP - Wichita Wichita Kansas 67214-3882 —
CCOP - Grand Rapids Grand Rapids Michigan 49503 —
CCOP - Kalamazoo Kalamazoo Michigan 49007-3731 —
CCOP - Kansas City Kansas City Missouri 64131 —
CCOP - Hematology-Oncology Associates of Central New York East Syracuse New York 13057 —
CCOP - Southeast Cancer Control Consortium Goldsboro North Carolina 27534-9479 —
CCOP - Columbus Columbus Ohio 43215 —
CCOP - Columbia River Oncology Program Portland Oregon 97225 —
CCOP - Greenville Greenville South Carolina 29615 —
CCOP - Northwest Tacoma Washington 98405-0986 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00397930, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 20, 2017 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00397930 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →